)
)
Tricida Investor Relations Material
Latest events
Q2 2022
Tricida
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Tricida Inc
Access all reports
Tricida Inc. is a pharmaceutical company focused on developing therapies for chronic kidney disease (CKD). The company’s lead investigational drug is designed to treat metabolic acidosis, a common complication in patients with CKD, which can lead to disease progression. Tricida aims to address unmet medical needs in the nephrology space by developing therapies that improve kidney health and patient outcomes. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
TCDA
Country
🇺🇸 United States